AVEO Oncology News Releases http://investor.aveooncology.com/ AVEO Oncology News Releases en AVEO Oncology to Present at the 2019 BIO International Convention http://investor.aveooncology.com/news-releases/news-release-details/aveo-oncology-present-2019-bio-international-convention CAMBRIDGE, Mass. --(BUSINESS WIRE)--May 29, 2019-- AVEO Oncology (NASDAQ: AVEO ) today announced that Mike Ferraresso , Senior Vice President, Business Analytics and Commercial Operations, will present at the 2019 BIO International Convention in Philadelphia on Wednesday, June 5, 2019 at 4:30 p.m. Wed, 29 May 2019 07:00:00 -0400 AVEO Oncology News Releases 14206 AVEO Oncology Announces Presentations at the 2019 ASCO Annual Meeting http://investor.aveooncology.com/news-releases/news-release-details/aveo-oncology-announces-presentations-2019-asco-annual-meeting CAMBRIDGE, Mass. --(BUSINESS WIRE)--May 15, 2019-- AVEO Oncology (NASDAQ: AVEO ) today announced two poster presentations at the upcoming American Society of Clinical Oncology ( ASCO ) Annual Meeting being held May 31-June 4, 2019 in Chicago, Illinois . Wed, 15 May 2019 17:00:00 -0400 AVEO Oncology News Releases 14196 AVEO Reports First Quarter 2019 Financial Results and Provides Business Update http://investor.aveooncology.com/news-releases/news-release-details/aveo-reports-first-quarter-2019-financial-results-and-provides CAMBRIDGE, Mass. --(BUSINESS WIRE)--May 9, 2019-- AVEO Oncology (NASDAQ: AVEO ) today reported financial results for the first quarter ended March 31, 2019 and provided a business update. “With a successful recent equity offering, together with the triggering of a FOTIVDA ® (tivozanib) milestone Thu, 09 May 2019 07:00:00 -0400 AVEO Oncology News Releases 14176 AVEO Oncology to Participate in the 5th Annual SunTrust Robinson Humphrey Life Sciences Summit http://investor.aveooncology.com/news-releases/news-release-details/aveo-oncology-participate-5th-annual-suntrust-robinson-humphrey CAMBRIDGE, Mass. --(BUSINESS WIRE)--May 1, 2019-- AVEO Oncology (NASDAQ:AVEO) today announced that members of the management team will participate in the 5th Annual SunTrust Robinson Humphrey Life Sciences Summit on Wednesday, May 8, 2019 . The conference is being held May 7-8 in New York . Wed, 01 May 2019 07:00:00 -0400 AVEO Oncology News Releases 14166 AVEO Oncology Announces $2M Milestone Payment From EUSA Pharma Related To Commercialization of FOTIVDA® in Spain http://investor.aveooncology.com/news-releases/news-release-details/aveo-oncology-announces-2m-milestone-payment-eusa-pharma-0 CAMBRIDGE, Mass. --(BUSINESS WIRE)--Apr. 23, 2019-- AVEO Oncology (NASDAQ:AVEO) today announced the triggering of a $2 million milestone payment to AVEO from EUSA Pharma. The milestone payment relates to the reimbursement approval and commercial launch in Spain of FOTIVDA ® (tivozanib) as a first Tue, 23 Apr 2019 16:05:00 -0400 AVEO Oncology News Releases 14136 AVEO Pharmaceuticals, Inc. Announces Pricing of $25 Million Underwritten Public Offering http://investor.aveooncology.com/news-releases/news-release-details/aveo-pharmaceuticals-inc-announces-pricing-25-million CAMBRIDGE, Mass.--( BUSINESS WIRE )--AVEO Pharmaceuticals, Inc. (Nasdaq: AVEO) (“AVEO” or the “Company”), a biopharmaceutical company seeking to advance targeted medicines for oncology and other unmet medical needs, today announced the pricing of its previously announced underwritten public Wed, 03 Apr 2019 23:35:00 -0400 AVEO Oncology News Releases 14066 AVEO Pharmaceuticals, Inc. Announces Proposed Public Offering http://investor.aveooncology.com/news-releases/news-release-details/aveo-pharmaceuticals-inc-announces-proposed-public-offering CAMBRIDGE, Mass. --(BUSINESS WIRE)--Apr. 3, 2019-- AVEO Pharmaceuticals, Inc. (Nasdaq: AVEO ) (“AVEO” or the “Company”), a biopharmaceutical company seeking to advance targeted medicines for oncology and other unmet medical needs, today announced it has commenced an underwritten public offering of Wed, 03 Apr 2019 16:01:00 -0400 AVEO Oncology News Releases 14056 AVEO Oncology to Present at the H.C. Wainwright Global Life Sciences Conference http://investor.aveooncology.com/news-releases/news-release-details/aveo-oncology-present-hc-wainwright-global-life-sciences CAMBRIDGE, Mass. --(BUSINESS WIRE)--Apr. 2, 2019-- AVEO Oncology (NASDAQ: AVEO ) today announced that Michael Bailey , president and chief executive officer, will present at the H.C. Wainwright Global Life Sciences Conference in London on Tuesday, April 9, 2019 at 2:10 p.m. BST . Tue, 02 Apr 2019 07:00:00 -0400 AVEO Oncology News Releases 14046 AVEO and Biodesix Announce Positive Results from Phase Ib Ficlatuzumab-Cytarabine Trial in Patients with Relapsed and Refractory AML http://investor.aveooncology.com/news-releases/news-release-details/aveo-and-biodesix-announce-positive-results-phase-ib - Data presented during poster session at the AACR 2019 Annual Meeting - CAMBRIDGE, Mass. --(BUSINESS WIRE)--Apr. 1, 2019-- AVEO Oncology (NASDAQ:AVEO) and Biodesix, Inc. today announced results from an investigator-sponsored Phase Ib expansion cohort of ficlatuzumab, AVEO’s potent hepatocyte Mon, 01 Apr 2019 16:05:00 -0400 AVEO Oncology News Releases 14031 AVEO Reports Full Year 2018 Financial Results and Provides Business Update http://investor.aveooncology.com/news-releases/news-release-details/aveo-reports-full-year-2018-financial-results-and-provides CAMBRIDGE, Mass. --(BUSINESS WIRE)--Mar. 14, 2019-- AVEO Oncology (NASDAQ: AVEO ) today reported financial results for the full year ended December 31, 2018 and provided a business update. “The results of TIVO -3, presented in February at the 2019 ASCO GU Symposium, underscore a unique activity and Thu, 14 Mar 2019 16:05:00 -0400 AVEO Oncology News Releases 14006